Does PALIVIZUMAB Cause Nasopharyngitis? 462 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 462 reports of Nasopharyngitis have been filed in association with PALIVIZUMAB (Synagis). This represents 4.1% of all adverse event reports for PALIVIZUMAB.
462
Reports of Nasopharyngitis with PALIVIZUMAB
4.1%
of all PALIVIZUMAB reports
4
Deaths
206
Hospitalizations
How Dangerous Is Nasopharyngitis From PALIVIZUMAB?
Of the 462 reports, 4 (0.9%) resulted in death, 206 (44.6%) required hospitalization, and 3 (0.6%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALIVIZUMAB. However, 462 reports have been filed with the FAERS database.
What Other Side Effects Does PALIVIZUMAB Cause?
Respiratory syncytial virus infection (1,692)
Pyrexia (1,055)
Death (856)
Bronchiolitis (724)
Cough (665)
Pneumonia (657)
Dyspnoea (466)
Vomiting (445)
Influenza (398)
Product dose omission issue (381)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which PALIVIZUMAB Alternatives Have Lower Nasopharyngitis Risk?
PALIVIZUMAB vs PALONOSETRON
PALIVIZUMAB vs PAMIDRONATE
PALIVIZUMAB vs PAMIDRONIC ACID
PALIVIZUMAB vs PANCRELIPASE
PALIVIZUMAB vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE